Guideline Updates Prior AuthorizationAnthem Blue Cross and Blue Shield | CommercialJuly 1, 2025

Anthem Blue Cross and Blue Shield VA Precertification/Prior Authorization list change notification July 1, 2025

The following services will be added to precertification/prior authorization for the effective dates listed below.

Precertification/prior authorization responsibility

The ordering or rendering care provider of the service is responsible for completing the precertification/prior authorization process.

If the requirements are not met, those services may be deemed ineligible for payment.

Providers may appeal online through Availity Essentials (https://Availity.com) or with additional information, which may include medical records

HMO plans: HMO members may not have benefits for non‑emergency services rendered outside of the network and are subject to review.

PPO plans: Precertification/prior authorization for services requiring prior approval is highly recommended.

EPO plans: Precertification/prior authorization for services requiring prior approval is highly recommended. No out‑of‑network benefit is available with the exception of ER/Urgent Care and authorized services.

To request precertification/prior authorization with the Virginia plan:

Log onto Availity Essentials at https://Availity.com.

For maternity, medical, and surgical precertification/prior authorization, contact Provider Services via the number on the back of our member ID card.

For mental health and substance use precertification/prior authorization, call 800‑755‑0851. Professionals are available 24 hours a day, seven days a week.

Add to precertification/prior authorization:

Criteria

Criteria description

Code

Effective date

LAB.00035

Multi-biomarker Disease Activity Blood Tests for Rheumatoid Arthritis

0521U

10/01/2025

LAB.00040

Serum Biomarker Tests for Risk of Preeclampsia

0524U

10/01/2025

LAB.00003

In Vitro Chemosensitivity Assays and In Vitro Chemoresistance Assays

0525U

10/01/2025

SURG.00165

Histotripsy

0888T

10/01/2025

SURG.00135

Renal Sympathetic Nerve Ablation

0935T

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

15011

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

15013

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

15015

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

15017

10/01/2025

MED.00057

MRI Guided High Intensity Focused Ultrasound Ablation for Non-Oncologic Indications

61715

10/01/2025

SURG.00156

Implanted Artificial Iris Devices

66683

10/01/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

82233

10/01/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

82234

10/01/2025

LAB.00028,

LAB.00046

Blood-based Biomarker Tests for Multiple Sclerosis
Testing for Biochemical Markers for Alzheimer's Disease`

83884

10/01/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

84393

10/01/2025

LAB.00046

Testing for Biochemical Markers for Alzheimer's Disease

84394

10/01/2025

SURG.00135

Renal Sympathetic Nerve Ablation

C1735

10/01/2025

SURG.00135

Renal Sympathetic Nerve Ablation

C1736

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

C8002

10/01/2025

SURG.00162

Implantable Shock Absorber for Treatment of Knee Osteoarthritis

C8003

10/01/2025

SURG.00158

Implantable Peripheral Nerve Stimulation Devices as a Treatment for Pain

C9807

10/01/2025

SURG.00155

Cryoneurolysis

C9808

10/01/2025

SURG.00155

Cryoneurolysis

C9809

10/01/2025

DME.00053

Home Video-Assisted Robotic Rehabilitation Systems

E0739

10/01/2025

MED.00152

Outpatient Intravenous Insulin Therapy

G9147

10/01/2025

MED.00135

Gene Therapy for Hemophilia

J1414

10/01/2025

MED.00140, MED.00146

Gene Therapy for Beta Thalassemia
Gene Therapy for Sickle Cell Disease

J3392

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4346

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4347

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4348

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4349

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4350

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4351

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4352

10/01/2025

SURG.00011

Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting

Q4353

10/01/2025

UM AROW A2025M3530

Anthem Blue Cross and Blue Shield is the trade name of Anthem Health Plans of Virginia, Inc. Anthem Blue Cross and Blue Shield, and its affiliate HealthKeepers, Inc., serving all of Virginia except for the City of Fairfax, the Town of Vienna, and the area east of State Route 123, are independent licensees of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc.

VABCBS-CM-085466-25

PUBLICATIONS: July 2025 Provider Newsletter